
GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting
View Full Release
06/03/2023

New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing
View Full Release
06/03/2023

GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting
View Full Release
06/01/2023

Grail to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting
View Full Release
05/22/2023

GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023
View Full Release
04/19/2023

FirstHealth of the Carolinas to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection Blood Test
View Full Release
04/18/2023